Neoadjuvant chemoradiotherapy for thoracic esophageal squamous cell carcinoma: does everyone need it?
Objective. In accordance with clinical guidelines, neoadjuvant chemoradiotherapy (nCRT) is recommended as a beneficial option for treatment of thoracic esophageal squamous cell carcinoma (TESCC). However, some studies did not demonstrate potential benefits of nCRT. In this paper we compared treatmen...
Saved in:
Main Authors: | D. A. Chichevatov, E. N. Sinev, A. E. Glukhov, O. M. Seliverstova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2024-05-01
|
Series: | Сибирский онкологический журнал |
Subjects: | |
Online Access: | https://www.siboncoj.ru/jour/article/view/3034 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of cervical esophageal carcinoma: systematic review and meta-analysis
by: D. A. Chichevatov, et al.
Published: (2023-09-01) -
Results of combined and chemoradiation treatment of patients with thoracic esophageal cancer according to the data of the regional cancer center
by: E. A. Toneev, et al.
Published: (2023-11-01) -
Successful extirpation of a perforated esophagus after chemo radiotherapy in infiltrative ulcerative squamous cell carcinoma
by: T. S. Rogova, et al.
Published: (2023-06-01) -
Nimotuzumab plus chemotherapy and immunotherapy as first-line/neoadjuvant therapy for advanced esophageal squamous cell carcinoma
by: Qi Wang, et al.
Published: (2025-07-01) -
Pathologic complete response after neoadjuvant therapy for resectable esophageal squamous cell carcinoma: Endoscopic characteristics and implications
by: Peng Yuan, et al.
Published: (2025-01-01)